-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FY7se0SdO/XGZGze1WJNRlXiNHVivHRMRVjrR1I6NvRSXGg3dECm3ysvxdK+WAMo 7Ay51NcJNE/ea/ddm1QUpA== 0001369360-07-000027.txt : 20070119 0001369360-07-000027.hdr.sgml : 20070119 20070119175802 ACCESSION NUMBER: 0001369360-07-000027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070116 FILED AS OF DATE: 20070119 DATE AS OF CHANGE: 20070119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENENTECH INC CENTRAL INDEX KEY: 0000318771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942347624 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-225-1000 MAIL ADDRESS: STREET 1: 1 DNA WAY STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLARK IAN T CENTRAL INDEX KEY: 0001336504 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09813 FILM NUMBER: 07541759 BUSINESS ADDRESS: BUSINESS PHONE: 650-225-1000 MAIL ADDRESS: STREET 1: C/O GENENTECH, INC. STREET 2: 1 DNA WAY - MS #49 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2007-01-16 0 0000318771 GENENTECH INC DNA 0001336504 CLARK IAN T 1 DNA WAY SO SAN FRANCISCO CA 94080 0 1 0 0 EVP-COMMERCIAL OPERATIONS Common Stock 2007-01-16 4 M 0 5000 18.15 A 6342 D Common Stock 2007-01-16 4 S 0 5000 88 D 1342 D Non-Qualified Stock Option (right to buy) 18.15 2007-01-16 4 M 0 5000 88 D 2003-01-13 2013-01-13 Common Stock 5000 11167 D This stock option vests over four years, with the first 25% of the shares vesting one year from the grant date and 75% of the shares vesting in equal monthly increments over the following three years. This option may be immediately exercisable with the consent of Genentech. Ian T. Clark 2007-01-17 -----END PRIVACY-ENHANCED MESSAGE-----